NCT01962324View on ClinicalTrials.gov

Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 9, 2023

Study Completion Date

May 9, 2023

Conditions
Prostatic NeoplasmsLymphatic Metastasis
Interventions
RADIATION

SIB Dose-Escalation Radiotherapy

Trial Locations (1)

90185

Umeå University, Cancercenter, Umeå

All Listed Sponsors
lead

Umeå University

OTHER

NCT01962324 - Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer | Biotech Hunter | Biotech Hunter